advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (101)
Showing records 1 to 25
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation69181 Investigation of Diffusion Characteristics through Microfluidic Channels for Passive Drug Delivery Applications
Goudie MJ
Journal of Drug Delivery 2016; 2016: 7913616
69273 Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells
Hakkarainen JJ
International Journal of Pharmaceutics 2016; 511: 73-78
69141 Long-term topical application of preservative-free prostaglandin analogues evokes macrophage infiltration in the ocular adnexa
Trzeciecka A
European Journal of Pharmacology 2016; 788: 12-20
69485 Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma
Kim J
Investigative Ophthalmology and Visual Science 2016; 57: 4341-4346
69483 An upright eyedrop bottle: accuracy, usage of excess drops, and contamination compared to a conventional bottle
Davies IJ
Clinical Ophthalmology 2016; 10: 1411-1417
68922 Six-Month Intraocular Pressure Reduction with a Topical Bimatoprost Ocular Insert: Results of a Phase II Randomized Controlled Study
Brandt JD
Ophthalmology 2016; 123: 1685-1694
69203 Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations
Angmo D
International Ophthalmology 2017; 37: 423-428
69173 Ultrasound-mediated ocular delivery of therapeutic agents: a review
Lafond M
Expert Opinion on Drug Delivery 2016; 0: 1-12
68870 Delivery of steroids into the eye for the treatment of macular edema
Hadayer A
Expert Opinion on Drug Delivery 2016; 13: 1083-1091
69304 Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK)
Aguayo Bonniard A
Expert Opinion on Drug Metabolism and Toxicology 2016; 0: 1-11
69172 Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension
Aptel F
Current Medical Research and Opinion 2016; 32: 1457-1463
68930 Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy
Cho IS
Acta biomaterialia 2016; 39: 124-132
69143 Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial
Chabi A
International Journal of Clinical Pract 2016; 70: 577-586
69207 Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in Rabbits
Fu J
Molecular pharmaceutics 2016; 13: 2987-2995
69107 Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
Walimbe T
Clinical Ophthalmology 2016; 10: 821-827
68883 Preservative-free tafluprost/timolol fixed combination: a new opportunity in the treatment of glaucoma
Konstas AG
Expert Opinion in Pharmacotherapy 2016; 17: 1271-1283
69193 Assessment of alkoxylphenacyl-based polycarbonates as a potential platform for controlled delivery of a model anti-glaucoma drug
Manickavasagam D
European Journal of Pharmaceutics and Biopharmaceutics 2016; 107: 56-66
69203 Evaluation of physical properties and dose equivalency of generic versus branded latanoprost formulations
Wadhwani M
International Ophthalmology 2017; 37: 423-428
68930 Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy
Park CG
Acta biomaterialia 2016; 39: 124-132
68870 Delivery of steroids into the eye for the treatment of macular edema
Schaal S
Expert Opinion on Drug Delivery 2016; 13: 1083-1091
69304 Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK)
Yeung JY
Expert Opinion on Drug Metabolism and Toxicology 2016; 0: 1-11
69172 Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension
Choudhry R
Current Medical Research and Opinion 2016; 32: 1457-1463
69193 Assessment of alkoxylphenacyl-based polycarbonates as a potential platform for controlled delivery of a model anti-glaucoma drug
Wehrung D
European Journal of Pharmaceutics and Biopharmaceutics 2016; 107: 56-66
69181 Investigation of Diffusion Characteristics through Microfluidic Channels for Passive Drug Delivery Applications
Ghuman AP
Journal of Drug Delivery 2016; 2016: 7913616
69207 Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in Rabbits
Sun F
Molecular pharmaceutics 2016; 13: 2987-2995